129 related articles for article (PubMed ID: 9673420)
1. Effects of local inhibition of the cardiac renin-angiotensin system with CV-11974 in a canine ischaemia-reperfusion model.
So T; Nakashima Y; Imamura M; Arakawa K
Clin Exp Pharmacol Physiol; 1998; 25(7-8):503-9. PubMed ID: 9673420
[TBL] [Abstract][Full Text] [Related]
2. Influence of the angiotensin II AT1 receptor antagonist irbesartan on ischemia/reperfusion injury in the dog heart.
Preckel B; Schlack W; Gonzàlez M; Obal D; Barthel H; Thämer V
Basic Res Cardiol; 2000 Oct; 95(5):404-12. PubMed ID: 11099168
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of EXP3174, an angiotensin II antagonist and enalaprilat on myocardial infarct size in anaesthetized dogs.
Richard V; Ghaleh B; Berdeaux A; Giudicelli JF
Br J Pharmacol; 1993 Nov; 110(3):969-74. PubMed ID: 8298820
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of agiotensin II type I receptor antagonist, CV-11974, on ischemia and reperfusion injury of the liver.
Masuko H; Jin MB; Horiuchi H; Suzuki T; Taniguchi M; Shimamura T; Fukai M; Magata S; Ogata K; Ishikawa H; Fujita M; Nagashima K; Furukawa H; Todo S
Transplantation; 2001 Apr; 71(8):1034-9. PubMed ID: 11374397
[TBL] [Abstract][Full Text] [Related]
5. Combination of a calcium antagonist, a lipid-peroxidation inhibitor, and an angiotensin AT1-receptor antagonist provides additive myocardial infarct size-limiting effect in pigs.
Shimizu M; Wang QD; Sjöquist PO; Rydén L
J Cardiovasc Pharmacol; 1999 Oct; 34(4):512-7. PubMed ID: 10511125
[TBL] [Abstract][Full Text] [Related]
6. Cardioprotection with angiotensin converting enzyme inhibitor and angiotensin II type 1 receptor antagonist is not abolished by nitric oxide synthase inhibitor in ischemia-reperfused rabbit hearts.
Kawabata H; Ryomoto T; Ishikawa K
Hypertens Res; 2001 Jul; 24(4):403-9. PubMed ID: 11510753
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the role of the renin-angiotensin system in cardiac contractility utilizing the renin inhibitor remikiren.
van Kats JP; Sassen LM; Danser AH; Polak MP; Soei LK; Derkx FH; Schalekamp MA; Verdouw PD
Br J Pharmacol; 1996 Mar; 117(5):891-901. PubMed ID: 8851507
[TBL] [Abstract][Full Text] [Related]
8. Influence of angiotensin II type 1-receptor antagonist CV11974 on infarct size and adjacent regional function after ischemia-reperfusion in dogs.
Miyoshi H; Takayama Y; Kitashiro S; Izuoka T; Saito D; Imuro Y; Mimura J; Yamamoto S; Tokioka M; Iwasaka T
Jpn J Pharmacol; 2002 Jun; 89(2):120-5. PubMed ID: 12120753
[TBL] [Abstract][Full Text] [Related]
9. Effect of angiotensin converting enzyme inhibitor and angiotensin II type 1 receptor antagonist on metabolism and contraction in ischemia-reperfused rabbit heart.
Kawabata H; Ryomoto T; Ishikawa K
Jpn Circ J; 2000 Apr; 64(4):276-82. PubMed ID: 10783050
[TBL] [Abstract][Full Text] [Related]
10. Role of cardiac ATP-sensitive K+ channels induced by angiotensin II type 1 receptor antagonist on metabolism, contraction and relaxation in ischemia-reperfused rabbit heart.
Kawabata H; Ryomoto T; Ishikawa K
Jpn Circ J; 2001 May; 65(5):451-6. PubMed ID: 11348052
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II type 1 receptor blockade with candesartan protects the porcine myocardium from reperfusion-induced injury.
Shimizu M; Wang QD; Sjöquist PO; Rydén L
J Cardiovasc Pharmacol; 1998 Aug; 32(2):231-8. PubMed ID: 9700985
[TBL] [Abstract][Full Text] [Related]
12. The effects of the endothelin ETA receptor antagonist, FR 139317, on infarct size in a rabbit model of acute myocardial ischaemia and reperfusion.
McMurdo L; Thiemermann C; Vane JR
Br J Pharmacol; 1994 May; 112(1):75-80. PubMed ID: 8032665
[TBL] [Abstract][Full Text] [Related]
13. Lack of a centrally-mediated antihypertensive effect following acute or chronic central treatment with AT1-receptor antagonists in spontaneously hypertensive rats.
Bunting MW; Widdop RE
Br J Pharmacol; 1995 Dec; 116(8):3181-90. PubMed ID: 8719794
[TBL] [Abstract][Full Text] [Related]
14. Cardioprotection induced by AT1R blockade after reperfused myocardial infarction: association with regional increase in AT2R, IP3R and PKCepsilon proteins and cGMP.
Jugdutt BI; Xu Y; Balghith M; Moudgil R; Menon V
J Cardiovasc Pharmacol Ther; 2000 Oct; 5(4):301-11. PubMed ID: 11150400
[TBL] [Abstract][Full Text] [Related]
15. AT1 receptor blockade limits myocardial injury and upregulates AT2 receptors during reperfused myocardial infarction.
Jugdutt BI; Menon V
Mol Cell Biochem; 2004 May; 260(1-2):111-8. PubMed ID: 15228092
[TBL] [Abstract][Full Text] [Related]
16. Effects of the insurmountable angiotensin AT1 receptor antagonist candesartan and the surmountable antagonist losartan on ischemia/reperfusion injury in rat hearts.
Wang QD; Sjöquist PO
Eur J Pharmacol; 1999 Sep; 380(1):13-21. PubMed ID: 10513555
[TBL] [Abstract][Full Text] [Related]
17. Nicorandil suppressed ventricular arrhythmias in a canine model of myocardial ischaemia.
Vegh A; Györgyi K; Papp JG; Sakai K; Parratt JR
Eur J Pharmacol; 1996 Jun; 305(1-3):163-8. PubMed ID: 8813547
[TBL] [Abstract][Full Text] [Related]
18. The Interplay between the Renin Angiotensin System and Pacing Postconditioning Induced Cardiac Protection.
Babiker F; Al-Jarallah A; Joseph S
PLoS One; 2016; 11(11):e0165777. PubMed ID: 27814397
[TBL] [Abstract][Full Text] [Related]
19. AT1 receptor blockade in experimental myocardial ischemia/reperfusion.
Jalowy A; Schulz R; Heusch G
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S129-36. PubMed ID: 9892153
[TBL] [Abstract][Full Text] [Related]
20. Cardiac protection by ischaemic preconditioning is not mediated by myocardial stunning.
Matsuda M; Catena TG; Vander Heide RS; Jennings RB; Reimer KA
Cardiovasc Res; 1993 Apr; 27(4):585-92. PubMed ID: 8324790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
